Recent clinical trials that compared the external artificial pancreas with conventional diabetes management methods shows the 'bionic pancreas' has promise. The artificial organ works much like a functional organic pancreas: it stimulates and adapts insulin production.
Artificial Pancreas Compared to Insulin Pump
When the new artificial pancreas was compared to the insulin pump, which is currently the most technologically advanced way to deliver a steady stream of insulin into the blood, the artificial pancreas is just as effective. When it comes to reducing the risk of hypoglycemia (low blood sugar), the artificial pancreas actually out-performs the pump, reducing the risk of dangerous blood sugar drops. Incidents of hypoglycemia with the artificial pancreas dropped dramatically, to less than 5 percent.
What Does This Mean for Diabetics?
Type 1 diabetics might soon be able to replace the faulty pancreas that gave them diabetes in the first place. Researchers hope that the artificial pancreas will be on the market by 2020. Further clinical trials are needed, but the U.S. Food and Drug Administration is helping to push along the development of the device.
This is great news for those living with Type 1 diabetes. Soon this new technology can give you the functioning pancreas you wish you were born with, making your diabetes management more effective than ever.